You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Residual Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ResiduAl Cancer With Liquid Biopsy Evaluation

Recruiting
  • Bladder Carcinoma
  • +14 more
  • Guardant Reveal
  • Redwood City, California
    Redwood City
Sep 7, 2022

Minimally Residual of Esophageal Cancer 001

Recruiting
  • Esophageal Carcinoma
  • Minimal Residual Disease
    • Shijiazhuang, Hebei, China
      Fourth Hospital of Hebei Medical University
    Jul 17, 2023

    Minimal Residual Disease Using Multi-omics Approach

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test
    • Shanghai, China
      Department of Pancreatic and Hepatobiliary Surgery, Fudan Univer
    Nov 29, 2023

    HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy Trial (SHR-A1811,

    Not yet recruiting
    • HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy
    • (no location specified)
    Nov 7, 2023

    Stage II-III Gastric Cancer Trial in Jinan, Qingdao, Yantai (MRD-guided therapy)

    Recruiting
    • Stage II-III Gastric Cancer
    • MRD-guided therapy
    • Jinan, Shandong, China
    • +4 more
    Nov 27, 2023

    Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)

    Not yet recruiting
    • Ovarian Cancer
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 9, 2023

    Pancreatic Cancer, Advanced Cancer, Metastatic Cancer Trial in Beijing (Later-line therapy)

    Recruiting
    • Pancreatic Cancer
    • +2 more
    • Later-line therapy
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Apr 10, 2023

    Cervical Cancer Trial in Chongqing (salvage surgery)

    Recruiting
    • Cervical Cancer
    • salvage surgery
    • Chongqing, Chongqing, China
      Chongqing Cancer Hospital
    Feb 20, 2023

    Danish Assessment of Minimal Residual Disease by Liquid Biopsies

    Recruiting
    • Colorectal Neoplasms
    • +5 more
      • Copenhagen, Capital Region Of Denmark, Denmark
      • +8 more
      Oct 13, 2023

      B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

      Recruiting
      • B-Cell Lymphoblastic Leukemia
      • Acute Lymphoblastic Leukemia
      • Tampa, Florida
        Moffitt Cancer Center
      Nov 28, 2023

      Pancreatic Cancer, Resectable Carcinoma Trial in Beijing (Later-line therapy)

      Recruiting
      • Pancreatic Cancer
      • Resectable Carcinoma
      • Later-line therapy
      • Beijing, China
        Department of Medical Oncology, Peking Union Medical College Hos
      Apr 10, 2023

      Residual Disease in Breast Cancer Remission After Primary

      Recruiting
      • Breast Cancer
      • minimally invasive preoperative image-guided vacuum-assisted biopsy
      • Milan, Italy
        Fondazione IRCCS Istituto Nazionale dei Tumori
      Jul 10, 2023

      Rectal Cancer Patients Based on ctDNA-MRD Technology

      Recruiting
      • Rectal Adenocarcinoma
      • +3 more
      • MRD detection
      • Guangzhou, Guangdong, China
        WeiWei Xiao
      Jul 31, 2023

      Brain Metastases, NSCLC Trial in Shanghai (EGFR-TK Inhibitor, Stereotactic radiotherapy)

      Recruiting
      • Brain Metastases
      • Non-small Cell Lung Cancer
      • EGFR-TK Inhibitor
      • Stereotactic radiotherapy
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Aug 27, 2023

      Pancreatic Cancer, Locally Advanced Trial in Beijing (Later-line therapy)

      Recruiting
      • Pancreatic Cancer
      • Locally Advanced
      • Later-line therapy
      • Beijing, China
        Department of Medical Oncology, Peking Union Medical College Hos
      Apr 10, 2023

      Colorectal Cancer, Colon Cancer, Rectum Cancer Trial in Houston (Regorafenib, XmAb20717)

      Not yet recruiting
      • Colorectal Cancer
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      May 31, 2023

      Breast Cancer, HER2-positive Breast Cancer Trial in Toronto (Neratinib)

      Not yet recruiting
      • Breast Cancer
      • HER2-positive Breast Cancer
      • Toronto, Ontario, Canada
        University Health Network: Princess Margaret Cancer Centre
      Oct 31, 2022

      Following Salvage Surgery for RESidual or reCurrent sqUamous

      Not yet recruiting
      • Head and Neck Cancer
      • Molecular Analyses
      • (no location specified)
      Mar 28, 2023

      Barrett Oesophagitis With Dysplasia Trial in Kansas City (Itraconazole in capsule form, Itraconazole in solution form)

      Recruiting
      • Barrett Oesophagitis With Dysplasia
      • Itraconazole in capsule form
      • Itraconazole in solution form
      • Kansas City, Kansas
        University of Kansas Medical Center
      Nov 1, 2022

      Validation for Early Cancer Detection and Minimal Residual

      Recruiting
      • Brain Cancer
      • +19 more
        • Duarte, California
        • +6 more
        Nov 10, 2022

        Minimal Residual Disease in Peripheral T-cell Lymphoma

        Active, not recruiting
        • Peripheral T Cell Lymphoma
        • Tumor biopsy
        • +2 more
        • Boston, Massachusetts
        • +2 more
        Dec 19, 2022

        Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

        Recruiting
        • Leukemia, Myeloid, Acute
        • Minimal Residual Disease
          • Chapel Hill, North Carolina
            North Carolina Cancer Hospital (NCCH)
          Feb 2, 2023

          Breast Cancer, Triple Negative Breast Cancer, Residual Cancer Trial in United States (Atezolizumab, Sacituzumab govitecan)

          Recruiting
          • Breast Cancer
          • +3 more
          • San Francisco, California
          • +8 more
          May 25, 2022

          Esophageal Cancer Trial (Blood sample)

          Not yet recruiting
          • Esophageal Cancer
          • Blood sample
          • (no location specified)
          Jan 19, 2023

          Measurable Residual Disease in Acute Myeloid Leukemia as

          Terminated
          • Leukemia, Myeloid, Acute
          • Measurable residual disease measured by flow cytometry
          • Heidelberg, BW, Germany
            University Hospital Heidelberg
          Sep 12, 2022